Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Return on Sales: 2016-2024

Historic Return on Sales for Akebia Therapeutics (AKBA) over the last 9 years, with Dec 2024 value amounting to -0.43%.

  • Akebia Therapeutics' Return on Sales fell 319.00% to -0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.07%, marking a year-over-year decrease of 319.00%. This contributed to the annual value of -0.43% for FY2024, which is 476.00% up from last year.
  • According to the latest figures from FY2024, Akebia Therapeutics' Return on Sales is -0.43%, which was up 91.65% from -5.19% recorded in FY2023.
  • Akebia Therapeutics' 5-year Return on Sales high stood at -0.32% for FY2022, and its period low was -5.19% during FY2023.
  • For the 3-year period, Akebia Therapeutics' Return on Sales averaged around -1.98%, with its median value being -0.43% (2024).
  • Per our database at Business Quant, Akebia Therapeutics' Return on Sales skyrocketed by 2,666bps in 2020 and then crashed by 487bps in 2023.
  • Akebia Therapeutics' Return on Sales (Yearly) stood at -1.31% in 2020, then decreased by 3bps to -1.33% in 2021, then spiked by 101bps to -0.32% in 2022, then crashed by 487bps to -5.19% in 2023, then spiked by 476bps to -0.43% in 2024.